tiprankstipranks
Trending News
More News >
NOXXON Pharma NV (FR:ALTME)
:ALTME
France Market

NOXXON Pharma NV (ALTME) Technical Analysis

Compare
3 Followers

Summary of all the Indicators

Overall Consensus
Buy
13Bullish
2Neutral
7Bearish
Technical Analysis Consensus
Sell
3Bullish
2Neutral
5Bearish
Moving Average Consensus
Strong Buy
10Bullish
0Neutral
2Bearish
NOXXON Pharma NV’s (ALTME) Moving Averages Convergence Divergence (MACD) indicator is <0.01, suggesting NOXXON Pharma NV is a Sell.
NOXXON Pharma NV’s (ALTME) 20-Day exponential moving average is 0.07, while NOXXON Pharma NV’s (ALTME) share price is <€0.1, making it a Buy.
NOXXON Pharma NV’s (ALTME) 50-Day exponential moving average is 0.07, while NOXXON Pharma NV’s (ALTME) share price is <€0.1, making it a Buy.

NOXXON Pharma NV (ALTME) Pivot Points

May 25, 2025, 02:36 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.07
0.07
0.08
0.08
0.08
0.08
0.09
Fibonacci
0.07
0.08
0.08
0.08
0.08
0.08
0.08
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

NOXXON Pharma NV (ALTME) Moving Averages

May 25, 2025, 02:36 PM
Period
Simple
Exponential
MA5
0.08Buy
0.08Buy
MA10
0.07Buy
0.08Buy
MA20
0.07Buy
0.07Buy
MA50
0.07Buy
0.07Buy
MA100
0.07Buy
0.07Buy
MA200
0.09Sell
0.09Sell
NOXXON Pharma NV’s (ALTME) 10-Day exponential moving average is 0.08, while NOXXON Pharma NV’s (ALTME) share price is <€0.1, making it a Buy.
NOXXON Pharma NV’s (ALTME) 100-Day exponential moving average is 0.07, while NOXXON Pharma NV’s (ALTME) share price is <€0.1, making it a Buy.
NOXXON Pharma NV’s (ALTME) stock price is <€0.1 and NOXXON Pharma NV’s (ALTME) 50-day simple moving average is 0.07, creating a Buy signal.
NOXXON Pharma NV’s (ALTME) stock price is <€0.1 and NOXXON Pharma NV’s (ALTME) 100-day simple moving average is 0.07, creating a Buy signal.
NOXXON Pharma NV’s (ALTME) stock price is <€0.1 and NOXXON Pharma NV’s (ALTME) 200-day simple moving average is 0.09, creating a Sell signal.

NOXXON Pharma NV (ALTME) Technical Indicators

May 25, 2025, 02:36 PM
Name
Value
Implied Action
RSI (14)
71.55
Sell
STOCH (9,6)
84.26
Sell
STOCHRSI (14)
88.45
Sell
MACD (12,26)
<0.01
Sell
ADX (14)
29.21
Neutral
Williams %R
-23.53
Buy
CCI (14)
183.03
Sell
ATR (14)
<0.01
-
Ultimate Oscillator
64.95
Neutral
ROC
24.24
Buy
NOXXON Pharma NV’s (ALTME) Relative Strength Index (RSI) is 71.55, creating a Sell signal.
NOXXON Pharma NV’s (ALTME) Trend Strength Indicator (ADX) is 29.21, creating a Neutral signal.
NOXXON Pharma NV’s (ALTME) Commodity Channel Index (CCI) is 183.03, creating a Sell signal.
NOXXON Pharma NV’s (ALTME) Price Rate of Change (ROC) is 24.24, creating a Buy signal.

FAQ

Is ALTME a Buy, Hold, or Sell?
Based on ALTME’s technical indicators, ALTME is a Buy.
    What is ALTME’s RSI (14)?
    ALTME’s RSI (14) is 71.55, which suggests ALTME is a Sell.
      What is ALTME’s MACD?
      ALTME’s MACD is <0.01, which suggests ALTME is a Sell.
        What is ALTME’s 5-day moving average?
        ALTME’s 5-day moving average is 0.08, which suggests ALTME is a Buy.
          What is ALTME’s 20-day moving average?
          ALTME 20-day moving average is 0.07, which suggests ALTME is a Buy.
            What is ALTME’s 50-day moving average?
            ALTME’s 50-day moving average is 0.07, which suggests ALTME is a Buy.
              What is ALTME’s 200-day moving average?
              ALTME’s 200-day moving average is 0.09, which suggests ALTME is a Sell.
                What is ALTME’s Williams % R (14)?
                ALTME’s Williams % R (14) is -23.53, which suggests ALTME is a Buy.
                  What is ALTME’s CCI (14)?
                  ALTME’s CCI (14) is 183.03, which suggests ALTME is a Sell.
                    What is the share price of NOXXON Pharma NV?
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis